Indica Labs
About Indica Labs
Indica Labs is a global leader in AI-powered digital pathology software and services, providing comprehensive solutions for quantitative evaluation and management of whole slide images. Their flagship platforms, HALO® and HALO AI, leverage artificial intelligence and computer vision algorithms to enable fast and precise analysis of tissue samples, which is critical for advancing research and diagnostics in various medical fields.
For physicians, Indica Labs’ offerings, including HALO AP® and HALO AP Dx, are designed to streamline diagnostic workflows, enhance accuracy, and facilitate collaboration in anatomic pathology. These platforms have received regulatory clearances in multiple markets for primary diagnosis and support high-throughput, whole-slide tissue analysis across diverse areas such as immuno-oncology, oncology, transplant science, neuroscience, ophthalmology, metabolism, respiratory, and tox pathology. The company also provides specialized Pharma Services, offering quantitative image analysis studies, including those compliant with Good Clinical Practice (GCP) standards, to support pharmaceutical companies, diagnostic labs, and research organizations in their biomarker programs and companion diagnostics development.
Focus Areas
Business Intelligence
| Key Investors | Leica Biosystems (strategic investment) |
| Partnerships | Leica Biosystems (strategic investment, exclusive reseller of IMS products, CDx development), Paige (integration of Diagnostic AI models into HALO AP®), Amazon Web Services (AWS) (cloud services, deep archive module, APN member), Hamamatsu Photonics K.K. (FDA clearance for HALO AP Dx with NanoZoomer® S360MD Slide scanner), Histofy (integration of AI tools into HALO AP®), Lunit (integration of Lunit SCOPE PD-L1 into HALO AP®) |
| Technology | HALO® (image analysis platform), HALO AI (deep learning classification and segmentation), HALO Link (collaborative image management), HALO AP® (enterprise digital pathology for clinical workflows), HALO AP Dx (FDA-cleared for primary diagnosis), Cloud Services (AWS hosted), AI-native digital pathology platform, deep learning, computer vision, open pathology, APIs, DICOM compatibility |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Indica Labs' platforms significantly enhance diagnostic accuracy and efficiency through AI-powered quantitative analysis and streamlined workflows. The user-friendly interface makes reviewing complex cases and collaborating with colleagues much easier, especially for multidisciplinary team meetings like tumor boards. Their FDA-cleared HALO AP Dx and CE-IVDR marked HALO APu00ae provide confidence for primary diagnosis and enable remote work capabilities. The objective, pixel-level quantification of biomarkers is crucial for precision medicine and guiding targeted therapies. Furthermore, their commitment to an open ecosystem allows seamless integration of best-of-breed AI tools and existing LIS/HIS, empowering pathologists with choice and flexibility.
Indica Labs is dedicated to 'open pathology,' ensuring their HALO platforms are scanner agnostic and support a wide array of image file formats. They actively partner with leading image analysis and AI developers, including Lunit, Paige, Ibex Medical Analytics, and Visiopharm, to seamlessly integrate third-party AI solutions. Their platforms also offer deep expertise in custom integration and database migration, unifying diverse data streams into interoperable workflows with existing LIS/LIMS systems.
Reviews & Opinions
Videos
News, demos, and interviews about Indica Labs.
Videos load interactively. If none appear, search YouTube for Indica Labs →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]
